PPARGC1A and Alzheimer disease: In contrast, EGCG promoted the biogenesis of mitochondrial function in the AD model with Down’s syndrome through the Sirt1/PGC-1α signaling pathway via the upregulation of TFAM and Nrf1, in addition to mtDNA content [142].